Start for free
Start for free
EMBL Ventures logo

EMBL Ventures

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

EMBL Ventures is a German venture capital engaged in the financing and development of products and technologies in the healthcare sector.

Investor Profile

EMBL Ventures has made 20 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (45%)
  • Series B (30%)
  • Series C (15%)
  • Series D (10%)

Country Focus

  • Germany (65%)
  • United Kingdom (10%)
  • Ireland (10%)
  • Austria (10%)
  • Romania (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Advanced Materials
  • Chemical
  • Chemical Engineering
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EMBL Ventures frequently co-invest with?

Gimv
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 3
BioMedPartners
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
LSP BioVentures
LSP BioVentures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 3
Edmond de Rothschild Private Equity
Edmond de Rothschild Private Equity
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Forbion Capital Partners
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
Andera Partners
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Vesalius Biocapital Partners
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 2
Sofinnova Partners
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Epidarex Capital
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 3

Which angels does EMBL Ventures often collaborate with?

NB
Nicholas Benedict
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by EMBL Ventures?

Topas Therapeutics

Hamburg, Hamburg, Germany

A biotechnology company focused on developing products to address areas of major unmet need.

Advanced MaterialsBiotechnologyChemicalChemical Engineering
Series BJul 29, 2021
Amount Raised: $21,404,695
Topas Therapeutics

Hamburg, Hamburg, Germany

A biotechnology company focused on developing products to address areas of major unmet need.

Advanced MaterialsBiotechnologyChemicalChemical Engineering
Series BOct 19, 2020
Amount Raised: $25,890,577
Crescendo Biologics

Cambridge, Cambridgeshire, United Kingdom

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

BiotechnologyHealth CareTherapeutics
Series BApr 30, 2018
Amount Raised: $70,000,000
Arsanis

Vienna, Wien, Austria

Arsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.

BiotechnologyHealth CareLife Science
Series DApr 26, 2017
Amount Raised: $45,500,000
Luxendo

Heidelberg, Baden-Wurttemberg, Germany

Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.

BioinformaticsBiotechnologyManufacturing
Series AJan 12, 2017
Amount Raised: $8,493,056
Allecra Therapeutics

Weil Am Rhein, Baden-Wurttemberg, Germany

Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.

BiopharmaBiotechnologyPharmaceutical
Series BJun 15, 2016
Amount Raised: $24,780,328
Topas Therapeutics

Hamburg, Hamburg, Germany

A biotechnology company focused on developing products to address areas of major unmet need.

Advanced MaterialsBiotechnologyChemicalChemical Engineering
Series AMar 22, 2016
Amount Raised: $15,703,236
Luxendo

Heidelberg, Baden-Wurttemberg, Germany

Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.

BioinformaticsBiotechnologyManufacturing
Series AOct 14, 2015
Amount Raised: $6,884,437
Vira Therapeutics

Innsbruck, Tirol, Austria

ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic viruses.

BiotechnologyHealth CareMedicalTherapeutics
Series AJun 24, 2015
Amount Raised: $4,033,496
ImevaX

Munich, Bayern, Germany

ImevaX is a biopharmaceutical company founded in 2014 based in Munich, Germany

BiotechnologyHealth CareMedical
Series AOct 28, 2014
Amount Raised: $9,551,585
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator